Catalyst Pharmaceutical Partners shares owned by Barclays
Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Catalyst Pharmaceutical Partners
Tip: Access up to 7 years of quarterly data
All positions including Catalyst Pharmaceutical Partners held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Catalyst Pharmaceutical Partners by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $7.3M | 373k | 19.70 |
| 2025-06-30 | $8.0M | 369k | 21.70 |
| 2025-03-31 | $4.8M | 198k | 24.25 |
| 2024-12-31 | $5.1M | 244k | 20.87 |
| 2024-09-30 | $4.9M | 249k | 19.88 |
| 2024-06-30 | $1.7M | 108k | 15.49 |
| 2024-03-31 | $2.2M | 141k | 15.94 |
| 2023-12-31 | $5.1M | 303k | 16.81 |
| 2023-09-30 | $3.9M | 331k | 11.69 |
| 2023-06-30 | $8.9M | 663k | 13.44 |
| 2023-03-31 | $3.2M | 194k | 16.58 |
| 2022-12-31 | $5.4M | 292k | 18.60 |
| 2022-09-30 | $3.5M | 274k | 12.83 |
| 2022-06-30 | $34k | 4.8k | 7.07 |
| 2022-03-31 | $135k | 16k | 8.33 |
| 2021-12-31 | $797k | 118k | 6.76 |
| 2021-09-30 | $333k | 63k | 5.32 |
| 2021-06-30 | $857k | 149k | 5.76 |
| 2021-03-31 | $1.0M | 218k | 4.61 |
| 2020-12-31 | $849k | 255k | 3.34 |
| 2020-09-30 | $791k | 267k | 2.96 |
| 2020-06-30 | $1.3M | 278k | 4.62 |
| 2020-03-31 | $981k | 255k | 3.85 |
| 2019-12-31 | $424k | 113k | 3.75 |
| 2019-09-30 | $263k | 50k | 5.32 |
| 2019-06-30 | $239k | 62k | 3.84 |
| 2019-03-31 | $139k | 27k | 5.10 |
| 2018-12-31 | $2.0k | 1.1k | 1.76 |
| 2018-09-30 | $137k | 36k | 3.79 |
| 2018-06-30 | $22k | 7.1k | 3.11 |
| 2018-03-31 | $76k | 32k | 2.37 |
| 2017-12-31 | $52k | 14k | 3.88 |
| 2017-09-30 | $116k | 46k | 2.52 |
| 2017-06-30 | $0 | 16k | 0.00 |
| 2016-06-30 | $6.0k | 8.0k | 0.75 |
| 2015-12-31 | $17k | 8.3k | 2.05 |
| 2015-09-30 | $1.0k | 394 | 2.54 |
| 2015-06-30 | $6.0k | 1.4k | 4.16 |
Top funds holding Catalyst Pharmaceutical Partners
View all funds holding Catalyst Pharmaceutical Partners